Ridruejo E - Search Results

1

Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.

Piñero F, Anders M, Bermudez C, Demirdjian E, Varón A, Palazzo A, Rodriguez J, Beltrán O, da Fonseca LG, Ridruejo E, Caballini P, Tamagnone N, Reggiardo V, Cheinquer H, Araujo A, Arufe D, Marín JI, Ratusnu N, Manero E, Perez D, Villa M, Orozco F, Murga D, Marciano S, Bessone F, Silva M, Mendizabal M. Piñero F, et al. Among authors: ridruejo e. Ann Hepatol. 2023 Jul-Aug;28(4):101110. doi: 10.1016/j.aohep.2023.101110. Epub 2023 Apr 25. Ann Hepatol. 2023. PMID: 37100385 Free article.

2

Validation of the number connection test for identifying patients with minimal hepatic encephalopathy.

Adrover R, Barrio M, Malca Albuquerque M, Romé J, Borzi S, Cocozzella D, Ridruejo E, Curciarello J. Adrover R, et al. Among authors: ridruejo e. Acta Gastroenterol Latinoam. 2012 Jun;42(2):105-11. Acta Gastroenterol Latinoam. 2012. PMID: 22876712

3

Breath-ammonia testing of healthy subjects and patients with cirrhosis.

Adrover R, Cocozzella D, Ridruejo E, García A, Rome J, Podestá JJ. Adrover R, et al. Among authors: ridruejo e. Dig Dis Sci. 2012 Jan;57(1):189-95. doi: 10.1007/s10620-011-1858-9. Epub 2011 Aug 13. Dig Dis Sci. 2012. PMID: 21842240

4

Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life'.

Ridruejo E. Ridruejo E. Eur J Gastroenterol Hepatol. 2011 Feb;23(2):195. doi: 10.1097/MEG.0b013e328342af3d. Eur J Gastroenterol Hepatol. 2011. PMID: 21228684 No abstract available.

5

Hepatitis C treatment completion rates in routine clinical care.

Ridruejo E. Ridruejo E. Liver Int. 2010 Aug;30(7):1082; author reply 1083. doi: 10.1111/j.1478-3231.2010.02217.x. Epub 2010 Mar 1. Liver Int. 2010. PMID: 20214733 No abstract available.

6

Imatinib-induced fatal acute liver failure.

Ridruejo E, Cacchione R, Villamil AG, Marciano S, Gadano AC, Mandó OG. Ridruejo E, et al. World J Gastroenterol. 2007 Dec 28;13(48):6608-111. doi: 10.3748/wjg.v13.i48.6608. World J Gastroenterol. 2007. PMID: 18161937 Free PMC article.

7

Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon - Ribavirin in daily practice.

Ridruejo E, Adrover R, Cocozzella D, Fernández N, Reggiardo MV. Ridruejo E, et al. Ann Hepatol. 2010 Jan-Mar;9(1):46-51. Ann Hepatol. 2010. PMID: 20308722 Free article.

8

Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C.

Ridruejo E, Díaz C, Michel MD, Soler Pujol G, Martínez A, Marciano S, Mandó OG, Vilches A. Ridruejo E, et al. Ann Hepatol. 2010 Jul-Sep;9(3):271-7. Ann Hepatol. 2010. PMID: 20720267 Free article.

9

Thioctic acid-induced acute cholestatic hepatitis.

Ridruejo E, Castiglioni T, Silva MO. Ridruejo E, et al. Ann Pharmacother. 2011 Jul;45(7-8):e43. doi: 10.1345/aph.1Q035. Epub 2011 Jun 13. Ann Pharmacother. 2011. PMID: 21672886

10

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Ridruejo E, Adrover R, Silva MO. Ridruejo E, et al. Hepatology. 2011 Sep 2;54(3):1104-5; author reply 1105. doi: 10.1002/hep.24498. Hepatology. 2011. PMID: 21721024 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page